Search clinical trials for: Bispecific antibodies
Total 3938 results
-
Nantes University HospitalNot yet recruiting
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | TNBC, Triple Negative Breast CancerChina
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
-
Tianjin Medical University Cancer Institute and...RecruitingHepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectableChina
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingMantle Cell LymphomaUnited States
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
Kathelijn FischerRadboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaboratorsRecruitingAdolescent | Child | Hemophilia A With Inhibitor | Adult | Hemophilia A Without Inhibitor | Hemophilia A, SevereNetherlands
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
-
SparX Biotech(Jiangsu) Co., Ltd.RecruitingSolid Tumor | CRC | HNSCC | RCCUnited States
-
C. Babis AndreadisEli Lilly and Company; Genentech, Inc.; Adaptive BiotechnologiesNot yet recruitingMantle Cell LymphomaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
Academic and Community Cancer Research UnitedNot yet recruitingPrimary Mediastinal Large B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Hunan Province Tumor HospitalNot yet recruiting
-
Chulalongkorn UniversityRecruitingComparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia AJoint Bleed | Severe Hemophilia A Without InhibitorThailand
-
Nanfang Hospital, Southern Medical UniversityNot yet recruitingAdvanced Solid TumorsChina
-
National Cancer Institute (NCI)Not yet recruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Not yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingFollicular LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Kathleen DorritieBristol-Myers SquibbRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
RenJi HospitalShanghai Zhongshan Hospital; Ruijin HospitalRecruitingClear Cell Renal Cell Carcinoma、Resistance to ImmunotherapyChina
-
Guangzhou Excelmab Inc.RecruitingSafety and Efficacy of EX103 in Subjects With Relapsed/Refractory CD20-Positive Non-Hodgkin LymphomaCD20-positive Non-Hodgkin LymphomaChina
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationRecruitingMarginal Zone LymphomaFrance
-
Shanghai Zhongshan HospitalRecruitingBiliary Tract Cancer | Candonilimab | Claudin 18.2China
-
Qilu Pharmaceutical Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
LiuYingNot yet recruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
IGM Biosciences, Inc.RecruitingMultiple MyelomaUnited States
-
David HoUS Military HIV Research Program; Henry M. Jackson Foundation for the Advancement... and other collaboratorsRecruitingHIV-1-infectionTanzania
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Pleomorphic Variant Mantle Cell LymphomaUnited States
-
University of Colorado, DenverJanssen Research & Development, LLCRecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Shandong Cancer Hospital and InstituteRecruitingBreast Cancer | Small Cell Lung Cancer | Colorectal Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Squamous Cell Cancer of Head and NeckChina
-
Bio-Thera SolutionsSun Yat-sen UniversityRecruiting
-
Emory UniversityNational Cancer Institute (NCI); Xencor, Inc.RecruitingStage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Follic Lymph to Diff Large B-Cell Lymphoma | Transformed Marg Zone Lymph to Diff...United States
-
Bruno BockornyDana-Farber Cancer Institute; Agenus Inc.Not yet recruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Ductal AdenocarcinomaUnited States
-
Sun Yat-sen UniversityAkeso Pharmaceuticals, Inc.RecruitingNasopharyngeal Carcinoma | Nasopharyngeal CancerChina
-
Medical College of WisconsinMidwest Athletes Against Childhood CancerNot yet recruitingLymphoma | Leukemia | Hodgkin Disease | CD30-Positive Diffuse Large B-Cell Lymphoma | CD30+ Anaplastic Large Cell Lymphoma | CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma | CD30+ Immunoblastic Large T-Cell Cutaneous LymphomaUnited States
-
The Lymphoma Academic Research OrganisationRoche Pharma AGRecruitingFollicular LymphomaFrance
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingLocally Advanced Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Oncocytic CarcinomaUnited States
-
Shanghai Henlius BiotechNot yet recruiting
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdRecruitingAdvanced Non-small Cell Lung CancerChina
-
Shanghai Henlius BiotechRecruitingLymphoma | Advanced Tumors | Metastatic TumorsChina
-
Princess Maxima Center for Pediatric OncologyUniversity of Milano Bicocca; Amgen Europe B.VRecruitingAcute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaNorway, Finland, Denmark, Netherlands, Hungary, Argentina, Australia, Austria, Belgium, Czechia, France, Germany, Ireland, Italy, Japan, Portugal, Saudi Arabia, Sweden
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruitingAdvanced Solid TumorChina
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
Waterstone Hanxbio Pty LtdRecruitingRelapsed/Refractory LymphomaChina